Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues
Stimulator of Interferon Genes (STING) is a type of endoplasmic reticulum (ER)-membrane receptor. STING is activated by a ligand binding, which leads to an enhancement of the immune-system response. Therefore, a STING ligand can be used to regulate the immune system in therapeutic strategies. Howeve...
Main Authors: | Yuta Yanase, Genichiro Tsuji, Miki Nakamura, Norihito Shibata, Yosuke Demizu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/12/6847 |
Similar Items
-
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
by: Leila Motedayen Aval, et al.
Published: (2020-10-01) -
Design, Synthesis and Biological Evaluation of (2′,5′ and 3′5′-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)
by: Xin Xie, et al.
Published: (2020-11-01) -
Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
by: Jiajia Chang, et al.
Published: (2023-03-01) -
Dithioethanol (DTE)-Conjugated Deoxyribose Cyclic Dinucleotide Prodrugs (DTE-dCDNs) as STING Agonist
by: Zhiqiang Xie, et al.
Published: (2023-12-01) -
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
by: Jiawen Zhang, et al.
Published: (2024-01-01)